Study of Capmatinib in Indian Patients With MET Exon 14 Skipping Mutation Positive Advanced NSCLC.
Novartis
Novartis
Jemincare
Pfizer
Sirtex Medical
ShuGuang Hospital
Hangzhou Normal University
Hong Kong Children's Hospital
Pfizer
Celgene
Xoft, Inc.
AstraZeneca
Cytori Therapeutics
National Institutes of Health Clinical Center (CC)